In another study, the co-treatment of drug-resistant non-small cell lung carcinomas (NSCLC) (H157, H23 and H1299) with etoposide and TSA induced apoptotic through caspase-dependent pathway accompanied by a significant decrease in Bcl-xL expression allowing Bax activation. The gene discussed is BCL2L1; the disease is non-small cell lung carcinoma.